drugset / Trial / NCT06730516
Optic Nerve Perfusion Following Treatment with Latanoprost Versus Brimionidin Tartrate
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aimed to evaluate the effects of topical Latanoprost 0.005 % versus Brimionidin tartrate 0.2% on perfusion of optic nerve head This prospective interventional randomized study included 56 naive patients recently diagnosed with bilateral primary open angle glaucoma equally divided into two groups with 28 patients in each group
Timeline
- Start
- 2024-06-24
- Primary completion
- 2024-09-01
- Completion
- 2024-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brimonidine | Small molecule | 0.2 % | Topical |
| Subject | Latanoprost | Small molecule | 0.005 % | Topical |